Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study-Reference-Cited by-同舟云学术

Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study

Published:2019-02 Issue:2 Volume:111 Page:240-248
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Bradley Linda D.,Singh Sukhbir S.,Simon James,Gemzell-Danielsson Kristina^ORCID,Petersdorf Kathrin,Groettrup-Wolfers Esther,Ren Xiaowei,Zvolanek Michal,Seitz Christian^ORCID

Funder

Bayer

AbbVie

Allergan

PCORI

AMAG Pharmaceuticals

Amgen

Bayer Healthcare Pharmaceuticals

Sanofi

Shionogi

Valeant Pharmaceuticals

Novo Nordisk

Bayer HealthCare

New England Research Institute

Merck

Ferring

Gedeon Richter

MSD

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference39 articles.

1. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women;Zimmermann;BMC Womens Health,2012

2. Epidemiology of uterine fibroids: a systematic review;Stewart;BJOG,2017

3. The management of uterine leiomyomas;Vilos;J Obstet Gynaecol Can,2015

4. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence;Baird;Am J Obstet Gynecol,2003

5. Does life-course socioeconomic position influence racial inequalities in the occurrence of uterine leiomyoma? Evidence from the Pro-Saude Study;Boclin Kde;Cad Saude Publica,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial;F&S Reports;2024-06

2. Experimental and new investigational drugs for the treatment of uterine fibroids;Expert Opinion on Investigational Drugs;2024-04-17

3. Current and Emerging Treatment Options for Uterine Fibroids;Drugs;2023-11-03

4. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial;F&S Science;2023-11

5. Terapias emergentes en el tratamiento médico de los miomas uterinos;Medicina Clínica;2023-10